Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0000899243-19-002714

Options or other derivatives

  • Director acquired 657,895 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Martin Robert Daniel Director 2019-02-03 Grant or award · Common Stock Option +657,895 657,895 D
Loading xslF345X03/doc4.xml…